,Mexico's Regulation: COFEPRIS Eliminates the Review of Notices as Part of Administrative Simplification - Drugs
COFEPRIS announces the elimination of mandatory review for certain Notices to streamline processes and reduce administrative burdens as part of its digital transformation efforts.
COFEPRIS | Pharmaceuticals | Country Regulatory AffairsMexico's Regulation: The National Center for Pharmacovigilance and Technovigilance (CENAFyT) is Created -Drugs
Establishment of CENAFyT to enhance the coordination, monitoring, and reporting of medicine safety through improved pharmacovigilance in Mexico.
COFEPRIS | Pharmaceuticals | Country Regulatory AffairsColombia's Regulation: Information for Requesting Good Practice Certification Visits Manufacturing (BPx) - Drugs
Guidelines for pharmaceutical establishments on how to request certification, extension, renewal, or verification visits for Good Practice compliance with INVIMA in Colombia.
INVIMA | Pharmaceuticals | Country Regulatory AffairsColombia's Regulation: Decree of 2026: Regulating the Operation of Establishments Dedicated to the Extraction, Processing, Preservation, and Distribution of Blood and Blood Components and Medicinal Products Derived From Plasma and Serum, and Other Provisi
Regulation and modernization of standards for the operation, safety, and oversight of blood banks, blood components, and plasma-derived medicinal products in Colombia.
INVIMA | Pharmaceuticals | Country Regulatory AffairsBrazil's Regulation: The Highlights of the 3rd Dicol Public Meeting of 2026: Updated Rules Approved in the Sanitary Control of Foreign Trade and the List of Reference Medicines
ANVISA’s 3rd Dicol Public Meeting of 2026 highlighted updates to foreign trade sanitary controls, the List of Reference Medicines, regulatory timelines, and workforce appointments.
ANVISA | Pharmaceuticals | Country Regulatory Affairs
Consult
